18 results on '"Go R"'
Search Results
2. Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
3. Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design
4. “Real-life” data of the efficacy and safety of belantamab mafodotin in relapsed multiple myeloma—the Mayo Clinic experience
5. Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
6. Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
7. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
8. Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
9. Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
10. Clinical prevalence (diagnosed cases) of monoclonal gammopathy of undetermined significance in the US: estimating the burden on health care
11. Effect of the type of treatment facility on the outcome of acute myeloid leukemia in adolescents and young adults
12. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
13. Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
14. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
15. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
16. No association between marker D10S1423 and Alzheimer's disease
17. Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
18. Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2V617F mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.